Novartis6d
Novartis Scemblix® FDA approved in newly diagnosed CML, offering superior efficacy, and favorable safety and tolerability profile
Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...
Novartis7d
Αναζήτηση θέσεων εργασίας
Εξερευνήστε ευκαιρίες στη Novartis και στη Sandoz παρακάτω. Για επιπλέον ρόλους στη Novartis Gene Therapies (πρώην AveXis) επισκεφτείτε την Αναζήτηση ...
Novartis7d
Zaposlitev v Novartisu v Sloveniji
V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...
Novartis8d
Careers at Novartis in Slovenia
At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...
Novartis9d
Career search
Job Title Sort ascending Business Location Site Date Posted Senior Scientist - in-vivo pharmacology/oncology (Radioligand Therapy) (80-100%*) Regular, Full time Pharma Research Switzerland Basel (City ...
Novartis10d
Lediga tjänster
Bli en del av Novartis, här kan du se mer om vilka karriärmöjligheter som finns. Du kan också söka lediga tjänster hos Novartis Gene Therapies här. Chef de Produit Snr en Dermatologie H/F CDI, Full ...
Novartis11d
Openstaande vacatures bij Novartis
Bekijk hieronder de opportuniteiten bij Novartis. Voor functies bij Novartis Gene Therapies (voorheen AveXis), ga naar GTx Career Search. Equipment Specialist (m/w/d), Kundl, Tirol, Österreich Regulär ...
Novartis11d
Nové pracovní příležitosti
Prozkoumejte pracovní příležitosti ve společnosti Novartis v seznamu níže. Pro další pozice ve společnosti Novartis Gene Therapies (dříve AveXis) navštivte GTx Hledání práce. Drug Product Technologies ...
Novartis12d
Chronic Spontaneous Urticaria
Chronic spontaneous urticaria (CSU) is a serious condition that affects approximately 1.7 million people in the United States and is characterized by itchy hives, deep tissue swelling (angioedema), or ...
Novartis12d
Career Search
Explore opportunities with Novartis below.
Novartis12d
La afectación psicológica de la Leucemia Mieloide Crónica (LMC)
Recibir un diagnóstico de Leucemia Mieloide Crónica (LMC), igual que de cualquier otro tipo de cáncer, puede generar un gran shock en el paciente. Recibir un diagnóstico de Leucemia Mieloide Crónica ...